Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Del Prato

Showing results (11-20 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Clinical Practice. Supplement|November 7, 2000
Post-prandial hyperglycaemia--the necessity for better controlS Del Prato
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 14, 2002
In search of normoglycaemia in diabetes: controlling postprandial glucoseS Del Prato
Diabetes/Metabolism Research and Reviews|June 26, 2001
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitusS Del Prato, A Tiengo
International Journal of Clinical Practice|August 15, 2001
Mealtime glucose regulation in type 2 diabetesJ Tuomilehto, S Del Prato
Diabetes Research and Clinical Practice|January 1, 1988
The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelinesA Tiengo, S Del Prato
Lancet (London, England)|January 13, 1996
FIRI: fasting or false insulin resistance index?S Del Prato, P Pozzilli
Diabetes & Metabolism|July 22, 2008
Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequencesR Lupi, S Del Prato
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!]M Nauck, S Del Prato
Diabetes Research and Clinical Practice|August 1, 1995
What therapy do our NIDDM patients need? Insulin releasersG Crepaldi, S Del Prato
Cardiologia (Rome, Italy)|December 1, 1995
[Plurimetabolic syndrome: association of diabetes, dyslipidemia, and arterial hypertension]A Tiengo, S Del Prato
Pageof 21

Showing results (11-20 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Clinical Practice. Supplement|November 7, 2000
Post-prandial hyperglycaemia--the necessity for better controlS Del Prato
International Journal of Obesity and Related Metabolic Disorders : Journal of the International Association for the Study of Obesity|August 14, 2002
In search of normoglycaemia in diabetes: controlling postprandial glucoseS Del Prato
Diabetes/Metabolism Research and Reviews|June 26, 2001
The importance of first-phase insulin secretion: implications for the therapy of type 2 diabetes mellitusS Del Prato, A Tiengo
International Journal of Clinical Practice|August 15, 2001
Mealtime glucose regulation in type 2 diabetesJ Tuomilehto, S Del Prato
Diabetes Research and Clinical Practice|January 1, 1988
The combined treatment with insulin and sulfonylurea in non-insulin-dependent diabetic patients with secondary failure. Rationale and guidelinesA Tiengo, S Del Prato
Lancet (London, England)|January 13, 1996
FIRI: fasting or false insulin resistance index?S Del Prato, P Pozzilli
Diabetes & Metabolism|July 22, 2008
Beta-cell apoptosis in type 2 diabetes: quantitative and functional consequencesR Lupi, S Del Prato
Deutsche Medizinische Wochenschrift (1946)|March 27, 2013
[SGLT-2-inhibitor dapagliflozin: new treatment approach for diabetes type 2--new achievements, but also new questions!]M Nauck, S Del Prato
Diabetes Research and Clinical Practice|August 1, 1995
What therapy do our NIDDM patients need? Insulin releasersG Crepaldi, S Del Prato
Cardiologia (Rome, Italy)|December 1, 1995
[Plurimetabolic syndrome: association of diabetes, dyslipidemia, and arterial hypertension]A Tiengo, S Del Prato
Pageof 21